Source: International Congress 2017 – ME3 Genetics, pathology and therapy of neuroendocrine tumours of the lung



Rating:

Share or cite this content

Citations should be made in the following way:
G. Rossi (Aosta, Italy). Genetics, pathology, and therapy of neuroendocrine tumours of the lung. International Congress 2017 – ME3 Genetics, pathology and therapy of neuroendocrine tumours of the lung

Member's Comments

No comment yet.

Related content which might interest you: ME3 Genetics, pathology and therapy of neuroendocrine tumoursÿof the lung Source: Milan 2017 - Educational material Year: 2017 mRNA biomarker screening in pulmonary tumors showing neuroendocrine differentiation Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer Year: 2013 Neuroendocrine tumours of the lung other than SCLC Source: ERS webinar 2021: Neuroendocrine tumours of the lung other than SCLC Year: 2021 Correlation between clinical and pathological factors in resected lung carcinoid tumours Source: International Congress 2016 – Special issues in thoracic surgery Year: 2016 Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy Source: Eur Respir J 2012; 39: 1437-1442 Year: 2012 Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005 Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006 Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013 Pathology and immunohistochemistry of lung cancer Source: Eur Respir Mon; 2009: 44: 15–35 Year: 2009 Symptoms, signs and staging of lung cancer Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=86 Year: 2001 Potential genetic markers for the early diagnosis of peripheral and metastatic lung cancer Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers Year: 2015 Tumor-derived tumor necrosis factor-α promotes Lewis lung cancer-induced malignant pleural effusions in mice Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer Year: 2006 Lung cancer: immunopathology Source: ISSN=1025-448x, ISBN=1-904097-18-9, page=48 Year: 2001 EGFRmutations are associated with higher brain metastasis radio-sensitivity than KRAS mutations or wild type EGFR in non-small cell lung cancer patients (NSCLC) Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series Year: 2014 Pre-invasive diseases of the lung Source: Eur Respir Mon; 2009: 44: 36–56 Year: 2009 Significance of expression of TGF-β in pulmonary metastasis in non-small cell lung cancer tissues Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015 General characteristics and therapeutic options in lung cancer in Turkey Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features Year: 2015 Loss of heterozygosity of PTEN in patients with non-small cell lung cancer treated and not treated with neoadjuvant chemotherapy Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013 CyberKnife radiosurgery for early stage nonsmall cell lung cancer Source: Annual Congress 2013 –Advances in the therapy of lung cancer Year: 2013